The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.
Open accessThe DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
Numerous longevity genes have been discovered in model organisms and altering their function results in prolonged lifespan. In mammals, some have speculated that any health benefits derived from manipulating these same pathways might be offset by increased cancer risk on account of their propensity to boost cell survival. The Sir2/SIRT1 family of NAD(+)-dependent deacetylases is proposed to underlie the health benefits of calorie restriction (CR), a diet that broadly suppresses cancer in mammals. Here we show that CR induces a two-fold increase SIRT1 expression in the intestine of rodents and that ectopic induction of SIRT1 in a beta-catenin-driven mouse model of colon cancer significantly reduces tumor formation, proliferation, and animal morbidity in the absence of CR. We show that SIRT1 deacetylates beta-catenin and suppresses its ability to activate transcription and drive cell proliferation. Moreover, SIRT1 promotes cytoplasmic localization of the otherwise nuclear-localized oncogenic form of beta-catenin. Consistent with this, a significant inverse correlation was found between the presence of nuclear SIRT1 and the oncogenic form of beta-catenin in 81 human colon tumor specimens analyzed. Taken together, these observations show that SIRT1 suppresses intestinal tumor formation in vivo and raise the prospect that therapies targeting SIRT1 may be of clinical use in beta-catenin-driven malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“We and other researchers have gathered compelling evidence, from yeast to mammals, supporting the idea that a loss of epigenetic information, resulting in changes in gene expression, leads to the loss of cellular identity [3–7].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325 · cited 1×
“b-catenin is the central effector in the canonical Wnt signaling pathway that controls stem cell maintenance, development and carcinogenesis [20].”
BackgroundActivation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905 · cited 1×
“. Constitutive activation of the β-catenin pathway has been found in 90% of colorectal cancers”
BackgroundModulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750 · cited 1×
“On the other hand, SIRT1 can be proapoptotic [12] and anti-proliferative [13,14], and consequently has been proposed to behave as a tumor suppressor in vivo.”
BackgroundCalorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., & Sinclair, D. A. (2004) · Science · doi:10.1126/science.1099196 · Cited by 1,924
Self-citationIncreased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis
Brack, A. S., Conboy, M. J., Roy, S., Lee, M., Kuo, C. J., Keller, C., & Rando, T. A. (2007) · Science · doi:10.1126/science.1144090 · Cited by 1,564 · cited 2×
“Interestingly, two recent studies have shown that increased Wnt signaling is associated with accelerated aging, suggesting that an attenuation of Wnt signaling might underlie CR and be beneficial not only for treating cancer but for more broadly attenuating diseases of aging [23,24].”
BackgroundMultiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC Gene
Su, L.-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., & Dove, W. F. (1992) · Science · doi:10.1126/science.1350108 · Cited by 1,536
Mammalian SIRT1 Represses Forkhead Transcription Factors
Motta, M. C., Divecha, N., Lemieux, M., Kamel, C., Chen, D., Gu, W., Bultsma, Y., McBurney, M., & Guarente, L. (2004) · Cell · doi:10.1016/s0092-8674(04)00126-6 · Cited by 1,357
Self-citationAssociation of the APC Gene Product with β-Catenin
Rubinfeld, B., Souza, B., Albert, I., Müller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., & Polakis, P. (1993) · Science · doi:10.1126/science.8259518 · Cited by 1,223 · cited 1×
“of the second allele leads to constitutive nuclear localization of bcatenin and adenoma formation [18,19].”
BackgroundSirt1 Regulates Aging and Resistance to Oxidative Stress in the Heart
Alcendor, R. R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., Tian, B., Wagner, T., Vatner, S. F., & Sadoshima, J. (2007) · Circulation Research · doi:10.1161/01.res.0000267723.65696.4a · Cited by 1,147
Cited by
Items 301–400 of 603
Positive regulation of β-catenin–PROX1 signaling axis by DBC1 in colon cancer progression
Yu, E. J., Kim, S.-H., Kim, H. J., Heo, K., Ou, C. Y., Stallcup, M. R., & Kim, J. H. (2015) · Oncogene · doi:10.1038/onc.2015.401 · Cited by 50
Deng, X., Zheng, H., Li, D., Xue, Y., Wang, Q., Shanjun, Y., Zhu, Y. T., & Deng, M. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.5920 · Cited by 42
“Previous studies have demonstrated that there is abnormal expression of miR-34a due to the lack of 1p36 in certain tumors and metabolic-associated diseases (16,17).”
Shen, Y., Xu, L., Ning, Z., Liu, L., Lin, J., Chen, H., & Meng, Z. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz067 · Cited by 41
Circadian rhythm and sleep influences on digestive physiology and disorders
Vaughn, B. V., Rotolo, S., & Roth, H. L. (2014) · ChronoPhysiology and Therapy · doi:10.2147/cpt.s44806 · Cited by 42
“85 Given the link between circadian rhythmicity and cancer, chronomodulated chemotherapy has emerged as a treatment alternative to conventional chemotherapy.”
Sirt1’s Complex Roles in Neuroprotection
Tang, B. L. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9414-2 · Cited by 41
“SIRT1 deacetylates b-catenin and promotes cytoplasmic localization of nuclear b-catenin, and could be tumor-suppressive in malignancies promoted by b-catenin signaling such as intestinal cancers ( Firestein et al. 2008 ).”
SirT1 brings stemness closer to cancer and aging
Calvanese, V., & Fraga, M. F. (2011) · Aging · doi:10.18632/aging.100272 · Cited by 39
“In support of this theory, Sirt1 overexpression in ApcMin/+ mice induces beta-catenin deacetylation, reducing colon tumor formation [35]; in addition, both genetic and druginduced Sirt1 activation inhibit growth and/or induce apoptosis in certain cancer models [18,30].”
BackgroundTaming the beast within: resveratrol suppresses colitis and prevents colon cancer
Hofseth, L. J., Singh, U. P., Singh, N. P., Nagarkatti, M., & Nagarkatti, P. S. (2010) · Aging · doi:10.18632/aging.100143 · Cited by 37
Cruz-Bravo, R. K., Guevara-González, R. G., Ramos‐Gómez, M., Oomah, B. D., Wiersma, P. A., Campos-Vega, R., & Loarca-Piña, G. F. (2013) · Genes & Nutrition · doi:10.1007/s12263-013-0359-1 · Cited by 39
“Furthermore, SIRT1 has been shown to inhibit colon cancer growth in mouse model (Yeung et al. 2004) and may be stimulated by polyphenols in HT-29 cells (Firestein et al. 2008).”
Ding, G., Hongwei, H., Hedai, L., Zhang, M., Qian, H., & Zhijun, L. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2326-0 · Cited by 38
“in colon tumor [26].”
Bamps, S., Wirtz, J., Savory, F. R., Lake, D., & Hope, I. A. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.10.001 · Cited by 39
Budayeva, H. G., & Cristea, I. M. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.061333 · Cited by 42
Pruitt, K. (2016) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.09.001 · Cited by 39
Song, N.-Y., Lee, Y.-H., Na, H.-K., Baek, J.-H., & Surh, Y.-J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.001 · Cited by 36
MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting Sirt1
Xu, J., Liu, P., Si, M.-J., & Ding, X. (2013) · Tumor Biology · doi:10.1007/s13277-013-0974-x · Cited by 36
RetractedOxysterols and Gastrointestinal Cancers Around the Clock
Kovač, U., Skubic, C., Bohinc, L., Rozman, D., & Režen, T. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00483 · Cited by 37
Cen, Y., & Sauve, A. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910342d · Cited by 39
Dietary energy balance modulates ovarian cancer progression and metastasis
Al-Wahab, Z. R., Tebbe, C., Chhina, J., Dar, S. A., Morris, R. T., Ali‐Fehmi, R., Giri, S., Munkarah, A. R., & Rattan, R. (2014) · Oncotarget · doi:10.18632/oncotarget.2168 · Cited by 38
“A specific role for sirtuins in cancer has not been defined yet, with reports demonstrating sirtuins to have a dual role in the promotion and suppression of tumors [28-30].”
BackgroundActivation and inhibition of sirtuins: From bench to bedside
Fiorentino, F., Fabbrizi, E., Mai, A., & Rotili, D. (2024) · Medicinal Research Reviews · doi:10.1002/med.22076 · Cited by 42
Enterocyte-Specific Inactivation of SIRT1 Reduces Tumor Load in the APC+/min Mouse Model
Leko, V., Park, G. J., Lao, U., Simon, J. A., & Bedalov, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066283 · Cited by 38
“When a SIRT1 transgene was overexpressed in the intestinal epithelium, APC + /min mice developed fewer intestinal polyps, which was attributed to the increased deacetylation and nuclear exclusion of b -catenin [40] and subsequently decreased proliferation rates of the tumor cells.”
InfluentialJung, T.-Y., Jin, G.-R., Koo, Y.-B., Jang, M.-M., Kim, C., Lee, S.-Y., Kim, H., Lee, S.-Y., Lee, S.-Y., Ju, B., et al. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0465-2 · Cited by 46
The Versatility of Sirtuin-1 in Endocrinology and Immunology
Rasha, F. A., Mims, B. M., Castro‐Piedras, I., Barnes, B. J., Grisham, M. B., Rahman, R. L., & Pruitt, K. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.589016 · Cited by 36
“While SIRT1 is shown to promote many cancer phenotypes, a positive regulator of many cancer hallmarks (Hanahan and Weinberg, 2011), and is overexpressed in human cancer specimens compared to normal tissue, some reports from transgenic mouse models have identified tumor suppressor properties of SIRT1 (Firestein et al.,…”
BackgroundSunami, Y., Araki, M., Hironaka, Y., Morishita, S., Kobayashi, M., Liew, E. L., Edahiro, Y., Tsutsui, M., Ohsaka, A., & Komatsu, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057633 · Cited by 39
“However, in a colon cancer mouse model, increased SIRT1 expression suppresses cell proliferation and tumor formation [23].”
BackgroundAltıntop, M. D., Temel, H. E., Sever, B., Çiftçi, G. A., & Kaplancıklı, Z. A. (2016) · Molecules · doi:10.3390/molecules21111598 · Cited by 35
“Overexpression of SIRT1 has been reported to increase growth and survival rates of some cancer cell lines and inhibit apoptosis [10–13].”
BackgroundZhou, S., Zhang, H., Li, J., Li, W., Su, M., Ren, Y., Ge, F., Zhang, H., & Shang, H. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108693 · Cited by 36
Sirt1 protects from K‐Ras‐driven lung carcinogenesis
Costa‐Machado, L. F., Martín‐Hernández, R., Sánchez‐Luengo, M. Á., Hess, K., Vales‐Villamarín, C., Barradas, M., Lynch, C. J., de la Nava, D., Díaz‐Ruiz, A., de Cabo, R., et al. (2018) · EMBO Reports · doi:10.15252/embr.201643879 · Cited by 36
“…ovarian tumors [15,16]; haploinsufficiency of Sirt1 has been described to accelerate tumor development in a p53 -heterozygous background [13], and its overexpression has been shown to block the growth of different types of tumors in cell culture experiments [17,18] and in mouse models [13,19 – 21].”
Breaking down the Contradictory Roles of Histone Deacetylase SIRT1 in Human Breast Cancer
Rifai, K. T., Idrissou, M., Penault-Llorca, F. M., Bignon, Y., & Bernard-Gallon, D. J. (2018) · Cancers · doi:10.3390/cancers10110409 · Cited by 35
“Tumor promoters, including c-Myc [16], N-Myc [17], cortactin (CTTN) [18], NF-κB [19], β-catenin [20], and HIF-1α [21].”
BackgroundZhang, Z., Li, N., Chen, M., Gu, X., Zhao, W.-W., Liu, M.-H., & Cheng, W. (2020) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2019.3334 · Cited by 34
Renoprotective effects of estrogen on acute kidney injury: the role of SIRT1
Mahani, F. D., Khaksari, M., & Raji-Amirhasani, A. (2021) · International Urology and Nephrology · doi:10.1007/s11255-020-02761-y · Cited by 36
“Among the class III HDACs, SIRT1 (silent information regulator 2 homolog 1) encoded by the gene SIRT1 acts as a tumor suppressor gene since SIRT1-deficient mice develop tumors in multiple tissues, while SIRT1 overexpression inhibits intestinal tumorigenesis in SIRT1 transgenic mice [40, 41].”
BackgroundRoles of SIRT1 in leukemogenesis
Chen, W., & Bhatia, R. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328360ab64 · Cited by 36
“Conditional SIRT1 overexpression reduces intestinal tumor formation in APCmin/þ mice [21], and thymic lymphoma in p53þ/ mice [22].”
BackgroundRay, U., Roy, S. S., & Chowdhury, S. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000458744 · Cited by 35
SIRT1 deacetylates KLF4 to activate Claudin‐5 transcription in ovarian cancer cells
Zhang, X., Chen, J., Sun, L., & Xu, Y. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26404 · Cited by 34
“Firestein et al reported that SIRT1 inactivation in intestinal epithelial cells leads to hyper-acetylation of β-catenin, a key driver of EMT and stem cell expansion, and colon cancer growth.(8) We have previously demonstrated that SIRT1 dampens EMT to attenuate ovarian cancer metastasis likely by deacetylating such tr…”
BackgroundNutrient withdrawal rescues growth factor-deprived cells from mTOR-dependent damage
Panieri, E., Toietta, G., Mele, M., Labate, V., Ranieri, S. C., Fusco, S., Tesori, V., Antonini, A., Maulucci, G., Spirito, M. D., et al. (2010) · Aging · doi:10.18632/aging.100183 · Cited by 38
“Deregulated function of these cascades either due to nutrient excess or abnormal cell responses, play a central role in metabolic diseases such as diabetes and its complications [1,2], in body ageing [3] and cancer [4,5].”
miR-30a suppresses lung cancer progression by targeting SIRT1
Guan, Y., Rao, Z., & Chen, C. (2017) · Oncotarget · doi:10.18632/oncotarget.23529 · Cited by 32
“However, other studies also suggest that SIRT1 may also have tumor-suppressive function in some mouse model [14, 15].”
BackgroundSirtuin 1 and oral cancer (Review)
Islam, S., Abiko, Y., Uehara, O., & Chiba, I. (2018) · Oncology Letters · doi:10.3892/ol.2018.9722 · Cited by 38
SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells
Lahusen, T. J., & Deng, C. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0584 · Cited by 34
“analyzing SIRT1-mutant mouse models (17, 30, 40).”
Shah, Z. H., Ahmed, S. U., Ford, J. R., Allison, S. J., Knight, J. R. P., & Milner, J. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06448-11 · Cited by 35
“The discovery of SIRT1 splice variants may also help resolve apparently conflicting observations reported for the effects of SIRT1 depletion on embryonic development (13, 14, 34, 54) and for the link between SIRT1 and cancer, in which SIRT1 has been identified as both a tumor suppressor and also as a cancer-specific s…”
BackgroundThe Multiple Mechanisms of Cell Death Triggered by Resveratrol in Lymphoma and Leukemia
Frazzi, R., & Tigano, M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034977 · Cited by 34
“Yet, there is also evidence pointing to the potential of SIRT1 to suppress the growth of intestinal and colon cancers, among others [54].”
BackgroundOverexpression of SIRT4 inhibits the proliferation of gastric cancer cells through cell cycle arrest
Hu, Y., Lin, J., Lin, Y., Chen, X., Zhu, G., & Huang, G. (2018) · Oncology Letters · doi:10.3892/ol.2018.9877 · Cited by 34
“By contrast, other studies demonstrated that SIRT1 expression is reduced in breast cancer (18) and its expression in a mouse model has been revealed to prevent the formation of intestinal tumors (19).”
SIRT1: a potential tumour biomarker and therapeutic target
Zhao, B., Li, X., Zhou, L., Wang, Y., & Shang, P. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1605519 · Cited by 32
“[42] observed precursor cells that undergo neoplastic transformation in colon cancer, finding that SIRT1 expression was up-regulated in intestines in response to calorie restriction.”
BackgroundActive regulator of SIRT1 is required for cancer cell survival but not for SIRT1 activity
Knight, J. R. P., Allison, S. J., & Milner, J. (2013) · Open Biology · doi:10.1098/rsob.130130 · Cited by 32
Expression and clinical significance of Sirt1 in colorectal cancer
Yu, D.-F., JIANG, S.-J., PAN, Z.-P., CHENG, W.-D., ZHANG, W.-J., YAO, X.-K., Li, Y., & Lun, Y. (2015) · Oncology Letters · doi:10.3892/ol.2015.3982 · Cited by 34
GUO, P., WANG, D., WANG, X., FENG, H., TANG, Y., SUN, R., ZHENG, Y., DONG, L., ZHAO, J., ZHANG, X., et al. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4957 · Cited by 30
“The precise biochemical mechanism for the sAPP α and A β formation remains unclear, although numerous studies have indicated the abnormal formations of these two parameters in patients with AD (30).”
Fekete, M., Lehoczki, A., Szappanos, Á., Zábó, V., Kaposvári, C., Horváth, A. Z., Farkas, Á., Fazekas‐Pongor, V., Major, D., Lipécz, Á., et al. (2025) · Nutrients · doi:10.3390/nu17081351 · Cited by 37
“The role of SIRT1 in carcinogenesis is dose-dependent, and several studies suggest that maintaining an appropriate level of SIRT1 is critical for metabolism and tissue homeostasis [140,141].”
Pharmacological Advantage of SIRT2-Selective versus pan-SIRT1–3 Inhibitors
Hong, J. Y., Fernandez, I. R., Anmangandla, A., Lü, X., Bai, J. J., & Lin, H. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00331 · Cited by 33
Coumestrol Induces Mitochondrial Biogenesis by Activating Sirt1 in Cultured Skeletal Muscle Cells
Seo, D.-B., Jeong, H. W., Lee, S.-J., & Lee, S. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf404882w · Cited by 33
Association of SIRT1 and HMGA1 expression in non-small cell lung cancer
Lin, S., & Peng, F. (2015) · Oncology Letters · doi:10.3892/ol.2015.3914 · Cited by 29
Guo, A. H., Baliira, R. K., Skinner, M. E., Kumar, S., Andren, A. C., Zhang, L., Goldsmith, R. S., Michán, S., Davis, N. J., Maccani, M. W., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16506-7 · Cited by 35
“SIRT5 expression is driven by the CAGGS promoter (Supplemental Figure 1A) (20).”
Self-citationStroma-derived miR-214 coordinates tumor dissemination
Orso, F., Virga, F., Dettori, D., Dalmasso, A., Paradžik, M., Savino, A., Pomatto, M. A. C., Quirico, L., Cucinelli, S., Coco, M., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02553-5 · Cited by 30
“Stroma miR‐214 promotes metastasis formation When exploring the potential contribution of stroma miR-214 in tumor progression coordination, we generated a total body miR-214 overexpression (miR-214over) mouse model, based on the Cre-loxP recombination system [43], and on the intervention of a BalancerCre mouse [16], t…”
MethodCommon mechanisms for calorie restriction and adenylyl cyclase type 5 knockout models of longevity
Yan, L., Park, J. Y., Dillinger, J., Lorenzo, M. S. D., Yuan, C., Lai, L., Wang, C., Ho, D. W. T., Tian, B., Stanley, W. C., et al. (2012) · Aging Cell · doi:10.1111/acel.12013 · Cited by 35
“are generally accepted (Banks et al., 2008; Firestein et al., 2008; de Oliveira et al., 2010; Srivastava & Haigis, 2011; Sundaresan et al., 2011).”
BackgroundInfluentialMCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm
Pangon, L., Mladenova, D. N., Watkins, L., van Kralingen, C., Currey, N., Al‐Sohaily, S., Lécine, P., Borg, J., & Kohonen‐Corish, M. R. J. (2014) · International Journal of Cancer · doi:10.1002/ijc.28967 · Cited by 30
“In line with this model, transient MCC expression resulted in b-cat-K49 deacetylation, which is also a welldescribed SIRT1 function.(21,31) Importantly, MCC bearing the patient derived mutation R506Q, which failed to repress b-cat transcriptional activity, also failed to deacetylate b-cat and failed to adequately bind…”
BackgroundSirtuin biology and relevance to diabetes treatment
Dong, X. C. (2012) · Diabetes Management · doi:10.2217/dmt.12.16 · Cited by 30
Ptk7 and Mcc, Unfancied Components in Non-Canonical Wnt Signaling and Cancer
Dunn, N. R., & Tolwinski, N. S. (2016) · Cancers · doi:10.3390/cancers8070068 · Cited by 33
“Mounting evidence suggests that DBC1 positively regulates β-catenin activity through the deacetylase SIRT1 [108,109].”
BackgroundSIRT1 inhibits the mouse intestinal motility and epithelial proliferation
Wang, Y., Shi, X., Qi, J., Li, X., Uray, K., & Guan, X. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00302.2011 · Cited by 30
“However, overexpression of SIRT1 in the intestinal epithelium suppresses the ability of -catenin to drive transcription and proliferation (9).”
BackgroundInfluentialWang, Y., Cui, R., Zhang, X., Qiao, Y., Liu, X., Chang, Y.-F., Yu, Y., Sun, F., & Wang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.7022 · Cited by 29
“SIRT1 overexpression is sufficient to suppress colon cancer growth [1], but SIRT1 is positively correlated with malignancy in other types of cancers [2].”
BackgroundExpression patterns and potential roles of SIRT1 in human medulloblastoma cells in vivo and in vitro
Ma, J., Li, H., Chen, X., Yang, X., Wang, Q., Wu, M., Kong, Q., Li, Z., & Liu, J. (2012) · Neuropathology · doi:10.1111/j.1440-1789.2012.01318.x · Cited by 28
“SIRT1 could also suppress intestinal carcinogenesis and the growth of colon cancer cells.(14) Although no convincible explanation has been so far available to clarify these controversial effects of SIRT1 on cancer cells, it is apparent that SIRT1 functions in a cell- or tissue-related fashion.”
BackgroundLoss of a single Hic1 allele accelerates polyp formation in ApcΔ716 mice
Mohammad, H. P., Zhang, W., Prevas, H., Leadem, B. R., Zhang, M., Herman, J. G., Hooker, C. M., Watkins, D. N., Karim, B. O., Huso, D. L., et al. (2011) · Oncogene · doi:10.1038/onc.2010.633 · Cited by 31
“However, another study showed the opposite effect, in that polyps were decreased in Apcmin/þ animals upon overexpression of Sirt1 in the intestine (Firestein et al., 2008).”
Dual SIRT1 expression patterns strongly suggests its bivalent role in human breast cancer
Rifai, K. T., Judes, G., Idrissou, M., Daures, M., Bignon, Y., Penault-Llorca, F. M., & Bernard-Gallon, D. J. (2017) · Oncotarget · doi:10.18632/oncotarget.23006 · Cited by 28
“SIRT1 overexpression has been reported in several human cancers, it was generally associated with poor prognosis and poor overall survival [24], whereas reduced SIRT1 expression was consistent with a tumorsuppressor role [12, 20].”
BackgroundMultifaceted roles of aerobic glycolysis and oxidative phosphorylation in hepatocellular carcinoma
Zhang, Y., Li, W., Bian, Y., Li, Y., & Cong, L. (2023) · PeerJ · doi:10.7717/peerj.14797 · Cited by 34
“, 2016), which can dynamically affect different types of tumours (Firestein et al., 2008; Sun et al., 2013).”
BackgroundSIRT1 Pathway Dysregulation in the Smoke-Exposed Airway Epithelium and Lung Tumor Tissue
Beane, J., Cheng, L., Soldi, R., Zhang, X., Liu, G., Anderlind, C., Lenburg, M. E., Spira, A. E., & Bild, A. H. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1043 · Cited by 26
“SIRT1 has also been shown to suppress intestinal tumor formation by deacetylation of b-catenin (47).”
Heshmati, M., Soltani, A., Sanaei, M., Nahid‐Samiei, M., Shirzad, H., Jami, M., & Ghatrehsamani, M. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109492 · Cited by 26
Vitamin D induces SIRT1 activation through K610 deacetylation in colon cancer
García-Martínez, J. M., Chocarro‐Calvo, A., Martínez‐Useros, J., Fernández‐Aceñero, M. J., Fiuza, C., Cáceres-Rentero, J., la Vieja, A. D., Barbáchano, A., Múñoz, A., Larriba, M. J., et al. (2023) · eLife · doi:10.7554/elife.86913 · Cited by 28
Song, X., Kong, F., Zong, Z., Ren, M., Meng, Q., Li, Y., & Sun, Z. (2019) · RSC Advances · doi:10.1039/c8ra09914f · Cited by 28
Costa, D. B. V., Alcaide, A., Pelizzaro‐Rocha, K. J., Talero, E., Ávila‐Román, J., García‐Mauriño, S., Pilli, R. A., de Carvalho, J. E., & Motilva, V. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.03.009 · Cited by 26
Liu, C.-L., Zhao, D., Li, J.-J., Liu, S., An, J.-J., Wang, D., Hu, F.-A., Qiu, C.-Y., & Cui, M.-H. (2021) · Neoplasma · doi:10.4149/neo_2021_210623n834 · Cited by 27
“Sirt1 has shown promising associations with protein deacetylation and is involved in numerous biological or pathological processes, such as energy metabolism, autophagy, aging, and inflammation [17, 18], especially its role in cancer [19].”
Jia, X., Liu, H., Ren, X., Li, P., Song, R., Li, X., Guo, Y.-D., & Li, X. (2022) · Oncogene · doi:10.1038/s41388-022-02447-y · Cited by 30
“Indeed, some studies have shown that SIRT1 is a tumor suppressor because it inhibits oncoproteins, such as β-catenin [45], Survivin [46] and NF-κb [47].”
BackgroundMicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cells
Ghasaban, F. T., Maharati, A., Akhlaghipour, I., & Moghbeli, M. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02925-7 · Cited by 28
“SIRT1 has been observed to exhibit tumor-suppressive or oncogenic roles in various malignancies [206, 207].”
BackgroundCronise, R. J., Sinclair, D. A., & Bremer, A. A. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0027 · Cited by 26
Self-citationMichán, S., Juan, A. M., Hurst, C. G., Cui, Z., Evans, L. P., Hatton, C. J., Pei, D. T., Ju, M., Sinclair, D. A., Smith, L. E. H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085031 · Cited by 24
“In contrast, a moderate overexpression (,4-fold) in cortical neurons confers a youthful gene transcription profile in old murine brains[38], and three to four-fold Sirt1 increase in the intestines of colon cancer prone mice[39], or in bone marrow lymphocyte progenitors of p53+/– lymphoma prone mice[38], protect both m…”
BackgroundSelf-citationHistones: Controlling Tumor Signaling Circuitry
Castilho, M. D. M. R. M. (2013) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.s5-001 · Cited by 33
“In contrast, SIRT1 is also considered a tumor suppressor gene due to its role in genomic stability, in limiting the replicative life span, in regulate cellular response to genotoxic stress and in the suppression of intestinal tumorigenesis [84-86].”
BackgroundThe sirtuins in the pathogenesis of cancer
Voelter‐Mahlknecht, S., & Mahlknecht, U. (2010) · Clinical Epigenetics · doi:10.1007/s13148-010-0008-0 · Cited by 25
Effects of SIRT1 silencing on viability, invasion and metastasis of human glioma cell lines
Li, Y., Chen, X., Cui, Y., Wei, Q., Chen, S., & Wang, X. (2019) · Oncology Letters · doi:10.3892/ol.2019.10063 · Cited by 28
“A previous study reported that SIRT1 serves numerous roles in cancer biology (13).”
BackgroundSrisuttee, R., Koh, S. S., Malilas, W., Moon, J., Cho, I.-R., Jhun, B. H., Horio, Y., & Chung, Y.-H. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.10.102 · Cited by 23
Targeting the Wnt Pathway in Cancer
Goss, K. H., & Kahn, M. R. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8023-6 · Cited by 24
Bakhtiari, N., Mirzaie, S., Hemmati, R., Moslemee-jalalvand, E., Noori, A. R., & Kazemi, J. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.05.012 · Cited by 25
Svensson, K., LaBarge, S. A., Martins, V. F., & Schenk, S. (2017) · Acta Physiologica · doi:10.1111/apha.12897 · Cited by 22
Kuo, S., Chio, C., Yeh, C., Ma, J., Liu, W., Lin, M., Lin, K., & Chang, C. (2021) · Aging Cell · doi:10.1111/acel.13340 · Cited by 22
“In epithelial cells, the SIRT1 deacetylation of β- catenin causes the release of β- catenin from the nucleus (Firestein et al., 2008).”
BackgroundEpigenetic Effects of Blackberry Extract on Human Colorectal Cancer Cells
Tatar, M., Varedi, M., & Naghibalhossaini, F. (2021) · Nutrition and Cancer · doi:10.1080/01635581.2021.1952454 · Cited by 22
“In murine models of colon cancer, the upregulation of SIRT1 by polyphenols has been shown to suppress In Vivo intestinal tumor development via deacetylation of β-catenin (43).”
BackgroundPromises and challenges of anticancer drugs that target the epigenome
Verbrugge, I., Johnstone, R. W., & Bots, M. L. (2011) · Epigenomics · doi:10.2217/epi.11.82 · Cited by 23
Identification of dysregulated microRNAs in canine malignant melanoma
Ushio, N., Rahman, M. M., Maemura, T., Lai, Y., Iwanaga, T., Kawaguchi, H., Miyoshi, N., Momoi, Y., & Miura, N. (2018) · Oncology Letters · doi:10.3892/ol.2018.9692 · Cited by 28
“SIRT1 acts as a tumor suppressor via β-catenin and has reminiscent effects on TP53 in colon cancer (49).”
BackgroundSaeed, M. E. M., Rahama, M. S., Kuete, V., Dawood, M., Elbadawi, M., Sugimoto, Y., & Efferth, T. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.152890 · Cited by 22
Aging and Cancer: Are Sirtuins the Link?
Rodríguez, R. M. A., & Fraga, M. F. (2010) · Future Oncology · doi:10.2217/fon.10.57 · Cited by 24
Carboxamide SIRT1 inhibitors block DBC1 binding via an acetylation-independent mechanism
Hubbard, B. P., Loh, C., Gomes, A. P., Li, J., Lu, Q., Doyle, T. L., Disch, J. S., Armour, S. M., Ellis, J. L., Vlasuk, G. P., et al. (2013) · Cell Cycle · doi:10.4161/cc.25268 · Cited by 22
Self-citationDynamics of m6A RNA Methylome on the Hallmarks of Hepatocellular Carcinoma
Sivasudhan, E., BLAKE, N. W., Lu, Z.-L., Meng, J., & Rong, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.642443 · Cited by 23
Zhang, W., Zhang, Y., Wang, Z., Tian, X., Huang, C., Yin, W., Wang, J., Xiong, W., Lu, W., Zheng, H., et al. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3223 · Cited by 21
“The results from a colon cancer model showed that the upregulated SIRT1 protein was the result of ectopic expression, which reduced cell proliferation and tumor formation (Firestein et al., 2008; Wang et al., 2008).”
BackgroundSubramaniyan, B., Jagadeesan, K., Ramakrishnan, S., & Ganeshan, M. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.05.027 · Cited by 21
Role of Leptin in Cancer: A Systematic Review
Samad, N. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.18.003091 · Cited by 22
“Stimulus for the increase and survival of cancer cells is sirtuin dependent NAD dependent deacetylase 1[SIRT1], a downstream target of leptin [18, 19].”
BackgroundSong, N., Na, H., Baek, J., & Surh, Y. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.030 · Cited by 21
SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells
Pinton, G., Zonca, S., Manente, A. G., Cavaletto, M., Borroni, E., Daga, A., Jithesh, P. V., Fennell, D. A., Nilsson, S. V., & Moro, L. (2016) · Oncotarget · doi:10.18632/oncotarget.7321 · Cited by 21
“Despite it has been described that induction of SIRT1 by caloric restriction reduces cell proliferation and tumor formation in a mouse model of colon cancer [20], SIRT1 abundance is increased in various types of tumors [21].”
Kabiljo, J., Murko, C., Pusch, O., & Zupkovitz, G. (2019) · Gene Expression Patterns · doi:10.1016/j.gep.2019.05.001 · Cited by 23
Analysis of 41 cancer cell lines reveals excessive allelic loss and novel mutations in theSIRT1gene
Han, J., Hubbard, B. P., Lee, J. H., Montagna, C., Lee, H., Sinclair, D. A., & Suh, Y. (2013) · Cell Cycle · doi:10.4161/cc.23056 · Cited by 21
“Overexpression of SIRT1 in APC mice results in suppression of intestinal tumorigenesis via attenuation of β-catenin activity.(21) Moreover, incidence of age-related spontaneous cancers, such as carcinomas and sarcomas, decreases in Sirt1 transgenic mice.”
BackgroundSelf-citationVijg, J., Maslov, A. Y., & Suh, Y. (2008) · Cell · doi:10.1016/j.cell.2008.11.008 · Cited by 20
“These results are in keeping with recent work showing that ectopic induction of SIRT1 in a mouse model of colon cancer decreases tumor formation (Firestein et al., 2008) and that mutations in SIRT1 cause genetic instability (Wang et al., 2008).”
ResultDickson, B. C., Riddle, N. D., Brooks, J. S., Pasha, T. L., & Zhang, P. J. (2013) · Human Pathology · doi:10.1016/j.humpath.2012.10.001 · Cited by 20
“Contradictory reports have suggested a potential role as a tumor suppressor or promoter, suggesting that any contribution of SIRT1 to neoplasia may be context dependent [10-16].”
BackgroundUSP7 deubiquitinates and stabilizes SIRT1.
Song, N., Cao, C., Tian, S., Long, M., & Liu, L. (2020) · The Anatomical Record · doi:10.1002/ar.24252 · Cited by 19
“SIRT1 is constitutively expressed in various tissues, such as the liver, heart, and skeletal muscle (Poulose and Raju, 2015; Ross et al., 2018; Yu et al., 2018), while aberrant SIRT1 expression has been linked to numerous human malignancies (Firestein et al., 2008).”
BackgroundZhang, J., Peng, J., Kong, D., Wang, X., Wang, Z., Liu, J., Yu, W., Wu, H., Long, Z., Zhang, W., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119716 · Cited by 21
The expression and correlation of SIRT1 and Phospho-SIRT1 in colorectal cancer.
Zhang, X., Chen, S., Cheng, M., Cao, F., & Cheng, Y. (2015) · PubMed Central · Cited by 19
Comprehensive analysis of a microRNA expression profile in pediatric medulloblastoma
Dai, J., Li, Q., Bing, Z., Zhang, Y., Niu, L., Yin, H., Yuan, G., & Pan, Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6490 · Cited by 19
“The effects of SIRT1 are controversial; the protein was considered to be a tumor promoter in neuroblastoma, prostate and skin cancer (26-28), whereas it was considered to be a tumor suppressor in breast and colon cancer (29,30).”
Keshavarz, G., Jalili, C., Pazhouhi, M., & Khazaei, M. (2019) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2020.011 · Cited by 19
MiR‐22 modulates the expression of lipogenesis‐related genes and promotes hepatic steatosis in vitro
Yang, Z., Qin, W., Huo, J., Zhuo, Q., Wang, J., & Wang, L. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.13026 · Cited by 21
Carprofen Analogues as Sirtuin Inhibitors: Enzyme and Cellular Studies
Mellini, P., Carafa, V., Rienzo, B. D., Rotili, D., Vita, D. D., Cirilli, R., Gallinella, B., Provvisiero, D. P., Maro, S. D., Novellino, E., et al. (2012) · ChemMedChem · doi:10.1002/cmdc.201200318 · Cited by 19
Sirtuins and Hypoxia in EMT Control
Aventaggiato, M., Barreca, F., Sansone, L., Pellegrini, L., Russo, M. A., Cordani, M., & Tafani, M. (2022) · Pharmaceuticals · doi:10.3390/ph15060737 · Cited by 20
Metadata
- Authors
- Firestein, R., Blander, G., Michan, S., Oberdoerffer, P., Ogino, S., Campbell, J., Bhimavarapu, A., Luikenhuis, S., de Cabo, R., Fuchs, C., Hahn, W. C., Guarente, L. P., & Sinclair, D. A.
- Affiliations
- Broad Institute (US)
- Massachusetts Institute of Technology (US)
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Sinclair, David A.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-04-16
- Volume
- 3
- Issue
- 4
- Pages
- e2020
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2289879
- OpenAlex
- W2158153532
- Cited by
- 588
- References
- 34
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 12 · 2023: 29 · 2022: 11 · 2021: 25 · 2020: 15 · 2019: 31 · 2018: 37 · 2017: 25 · 2016: 38 · 2015: 31 · 2014: 40 · 2013: 60 · 2012: 46
- FWCI
- 22.92
- Type
- journal article
- Language
- en
- Update notices
- correction (2024-06-06)
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Glenn Foundation for Medical Research
- National Space Biomedical Research Institute
- National Institutes of Health (NIH T32)
- National Institute on Aging (R01AG028730, R01AG019719)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- SIRT1, NAD+-dependent deacetylase, caloric restriction, intestinal tumorigenesis, colon cancer, β-catenin, protein deacetylation, cytoplasmic localization, cell proliferation, longevity genes
- MeSH terms
- Animals, Cell Nucleus, Colonic Neoplasms, Humans, Mice, Inbred C57BL, Models, Biological, Rats, Inbred F344, Gene Expression Regulation, Neoplastic, Sirtuins, Cell Proliferation, beta Catenin, Mice, Rats, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.